Treatment for epilepsy is a possible culprit for development of schizophrenia

Oct 20, 2009

Researchers say antiepilectic drug treatments administered when the brain is developing appear to trigger schizophrenia-like behavior in animal models. In humans, having a history of seizures in infancy is a significant risk factor for development of schizophrenia later in life, but it is not known whether the elevated risk is due to seizures themselves, or from side effects antiepileptic drug (AED) treatment.

In research presented at the 39th annual meeting of the Society for Neuroscience, Georgetown University Medical Center researchers show that exposure to AEDs during critical periods of brain development in animal models increases schizophrenia-like behaviors.

"We know that early-life exposure to AEDs such as Phenobarbital triggers cell death in many regions associated with the onset of schizophrenia," explains Guillermo Palchik, a doctoral student in the department of pediatrics at GUMC. "This study not only suggests a relationship between the drugs and , but it raises important questions regarding the side effects of a widely-used class of drugs. Phenobarbital and other AEDs are not only used as a treatment for seizures but more generally in the treatment of migraines, neuropathic pain and mood disorders, among other ailments, and can be considered drugs of abuse."

Source: Georgetown University Medical Center (news : web)

Explore further: New study of self-awareness in MS has implications for rehabilitation

add to favorites email to friend print save as pdf

Related Stories

Schizophrenia studies should open dialog

Dec 01, 2006

Recent studies on schizophrenia treatment and cost should spark discovery of a third generation of treatment, a U.S. mental health advocacy group said.

Doctors raise questions, concerns about FDA suicide warning

Dec 09, 2008

Medical specialists at the nation's largest professional meeting on epilepsy discussed multiple questions and concerns they have about data presented by the FDA in support of its recent suicide alert on anticonvulsant drugs ...

Fine-tuning treatments for depression

Oct 18, 2009

New research clarifies how neurotransmitters like norepinephrine, serotonin, and dopamine, are regulated - a finding that may help fine-tune therapies for depression.

Recommended for you

From happiness to pain: Understanding serotonin's function

23 hours ago

In a study published today, in the scientific journal PLoS One, researchers at the Champalimaud Neuroscience Programme establish the effect of serotonin on sensitivity to pain using a combination of advanced genetic and op ...

The striatum acts as hub for multisensory integration

Aug 22, 2014

A new study from Karolinska Institutet in Sweden provides insight on how the brain processes external input such as touch, vision or sound from different sources and sides of the body, in order to select ...

User comments : 0